Literature DB >> 30600466

Therapeutic microRNAs in human cancer.

Gizem Ors-Kumoglu1, Sultan Gulce-Iz2,3, Cigir Biray-Avci4.   

Abstract

MicroRNAs (miRNAs) are RNA molecules at about 22 nucleotide in length that are non-coding, which regulate gene expression in the post-transcriptional level by performing degradation or blocks translation of the target mRNA. It is known that they play roles in mechanisms such as metabolic regulation, embryogenesis, organogenesis, differentiation and growth control by providing post-transcriptional regulation of gene expression. With these properties, miRNAs play important roles in the regulation of biological processes such as proliferation, differentiation, apoptosis, drug resistance mechanisms in eukaryotic cells. In addition, there are miRNAs that can be used for cancer therapy. Tumor cells and tumor microenvironment have different miRNA expression profiles. Some miRNAs are known to play a role in the onset and progression of the tumor. miRNAs with oncogenic or tumor suppressive activity specific to different cancer types are still being investigated. This review summarizes the role of miRNAs in tumorigenesis, therapeutic strategies in human cancer and current studies.

Entities:  

Keywords:  Cancer therapy; miRNA antagonists; miRNA masking; miRNA mimic; miRNA sponges

Year:  2019        PMID: 30600466      PMCID: PMC6368504          DOI: 10.1007/s10616-018-0291-8

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  20 in total

1.  Varicella-Zoster Virus (VZV) Small Noncoding RNAs Antisense to the VZV Latency-Encoded Transcript VLT Enhance Viral Replication.

Authors:  Punam Bisht; Biswajit Das; Paul R Kinchington; Ronald S Goldstein
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

2.  Deep Sequencing Identified Dysregulated Circulating MicroRNAs in Late Onset Preeclampsia.

Authors:  Danai Mavreli; Alexandra Lykoudi; George Lambrou; George Papaioannou; Nikolas Vrachnis; Sophia Kalantaridou; Nikolas Papantoniou; Aggeliki Kolialexi
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

Review 3.  Pancreatic Ductal Adenocarcinoma: MicroRNAs Affecting Tumor Growth and Metastasis in Preclinical In Vivo Models.

Authors:  Ulrich H Weidle; Fabian Birzele; Adam Nopora
Journal:  Cancer Genomics Proteomics       Date:  2019 Nov-Dec       Impact factor: 4.069

Review 4.  Cancer-associated miRNAs and their therapeutic potential.

Authors:  Jun Inoue; Johji Inazawa
Journal:  J Hum Genet       Date:  2021-06-04       Impact factor: 3.172

5.  MicroRNA-204 plays a role as a tumor suppressor in Newcastle disease virus-induced oncolysis in lung cancer A549 cells.

Authors:  Ying Liang; Wen-Yu Tian; Juan-Juan Huang; Ling-Xi Gao; Xiao-Hui Fan
Journal:  Oncol Lett       Date:  2021-04-21       Impact factor: 2.967

6.  miR-139-5p functions as a tumor suppressor in cervical cancer by targeting TCF4 and inhibiting Wnt/β-catenin signaling.

Authors:  Xia Ji; Hairong Guo; Shanyu Yin; Haiyan Du
Journal:  Onco Targets Ther       Date:  2019-09-20       Impact factor: 4.147

Review 7.  Role of miRNA-Regulated Cancer Stem Cells in the Pathogenesis of Human Malignancies.

Authors:  Abdul Q Khan; Eiman I Ahmed; Noor R Elareer; Kulsoom Junejo; Martin Steinhoff; Shahab Uddin
Journal:  Cells       Date:  2019-08-05       Impact factor: 6.600

8.  Homo Sapiens Circular RNA 0079993 (hsa_circ_0079993) of the POLR2J4 Gene Acts as an Oncogene in Colorectal Cancer Through the microRNA-203a-3p.1 and CREB1 Axis.

Authors:  Xiaohong Lu; Yuanjie Yu; Fei Liao; Shiyun Tan
Journal:  Med Sci Monit       Date:  2019-09-13

9.  Downregulation of hsa-microRNA-204-5p and identification of its potential regulatory network in non-small cell lung cancer: RT-qPCR, bioinformatic- and meta-analyses.

Authors:  Chang-Yu Liang; Zu-Yun Li; Ting-Qing Gan; Ye-Ying Fang; Bin-Liang Gan; Wen-Jie Chen; Yi-Wu Dang; Ke Shi; Zhen-Bo Feng; Gang Chen
Journal:  Respir Res       Date:  2020-02-26

10.  A modified protocol for successful miRNA profiling in human precision-cut lung slices (PCLS).

Authors:  Monika Niehof; Stella Marie Reamon-Buettner; Olga Danov; Tanja Hansen; Katherina Sewald
Journal:  BMC Res Notes       Date:  2021-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.